TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial

By sjmartinez • May 9, 2024

Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial. Nat Commun. 2024 May 8;15(1):3882. doi: 10.1038/s41467-024-48073-y. PMID: 38719809.

Tags: Dermatology, Publications

Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board

Blauvelt A, Prussick R, Merola JF, Shahriari M, Cather J, Eakin GS, McCormick Howard L, Lebwohl MG, Armstrong AW, Duffin KC. Clarifying Psoriasis Disease Severity:[...]

Dermatofibrosarcoma Protuberans of the Clavicular Skin in a 70-Year-Old Woman: Case Report and Management

Peng DS, Shen A, Kang Y, Yamamoto RK, Levins P. Dermatofibrosarcoma Protuberans of the Clavicular Skin in a 70-Year-Old Woman: Case Report and Management. Cureus.[...]

Helicobacter pylori as a risk factor for pemphigus and pemphigoid: A US large-scale cohort study using the TriNetX database

Kasperkiewicz M, Ludwig RJ, Curman P. Helicobacter pylori as a risk factor for pemphigus and pemphigoid: A US large-scale cohort study using the TriNetX database.[...]